Tag Archives: Bioheart

Update on Phase I Adipose Stem Cell Trial

Bioheart Inc, a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announces an update on the phase I safety trial using adipose derived cells.

Approximately four years ago in April, 2010, Bioheart initiated a study using adipose derived stem cells (AdipoCell(TM)) in congestive heart failure patients. In collaboration with the Regenerative Medicine Institute of Tijuana, Mexico, five congestive heart failure patients were successfully treated in the initial pilot trial at Hospital Angeles Tijuana. Patients underwent a mini-lipoaspiration procedure where 60ccs of fat were removed.

This fat was processed to obtain the stromal vascular fraction (SVF) which
Read More…

Bioheart Announces Cell Therapies Program in the Middle East for Congestive Heart Failure and Peripheral Arterial Disease Patients

(…) Bioheart’s MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells, that are grown from a patient’s own muscle. MyoCell® has been tested successfully on patients in four clinical trials. The REGEN trial is designed to test the safety and effectiveness of a composition of muscle stem cells that have been gene-modified to induce a greater than usual release of the SDF-1 protein. The SDF-1 protein is a molecule in the human body that, after an injury, is naturally released by most tissues to attract stem cells. The stem cells assist with the healing process.

Unlike
Read More…

Bioheart in Partnership With NorthStar on Physician Training in Stem Cell Techniques

Bioheart Inc previously announced that it is working with NorthStar Biotech to help promote regenerative medicine. NorthStar has announced that it will subsidize physicians to participate in the Ageless Regenerative Institute stem cell training program. The fully accredited CME training program includes a didactic lecture series followed by hands-on clinical training for physicians to learn to isolate stem cells for immediate use in their patients. The Ageless Regenerative Institute has successfully trained over 200 physicians and these physicians are utilizing both adipose and bone marrow derived stem cells as well as platelet rich plasma for orthopedics, aesthetics and other
Read More…